한글목차

임상시험용 공급품 시장의 규모는 최근, 현저한 성장을 달성하고 있습니다. 2025년 28억 6,000만 달러에서 2026년에는 31억 달러로, CAGR 8.3%로 확대할 전망입니다. 지난 수년간의 성장은 세계 임상시험 활동 증가, 다기관 임상시험 설계의 확대, 생물제제 및 전문의약품의 성장, CRO에 대한 아웃소싱 증가, 콜드체인 물류 인프라의 발전에 기인하는 것으로 보입니다.

임상시험 공급품 시장 규모는 향후 수년간 견고한 성장이 전망됩니다. 2030년에는 43억 3,000만 달러에 달하며, CAGR은 8.7%에 달할 전망입니다. 예측 기간 중의 성장 요인으로는 임상시험 프로토콜의 복잡성 증가, 분산형 및 가상 임상시험의 확대, 환자 중심 임상시험 모델에 대한 관심 증가, 디지털 임상시험 관리 툴에 대한 투자 증가, 지역 간 규제 감시 강화 등이 있습니다. 예측 기간 중 주요 동향으로는 통합 공급망 플랫폼 도입 확대, 온도 관리 물류 솔루션 사용 증가, 시험의 엔드투엔드 가시성에 대한 수요 증가, 적응형 포장 및 라벨링 서비스 확대, 컴플라이언스 및 추적성에 대한 관심 강화 등이 있습니다.

임상시험 용품 시장은 등록 임상시험 수 증가를 배경으로 큰 폭의 성장이 예상되고 있습니다. 새로운 치료법, 중재법, 진단 절차의 안전성과 유효성을 평가하는 데 필수적인 이러한 시험에는 의약품과 의료기기를 포함한 다양한 물품이 사용되고 있습니다. 구체적으로 2023년 5월 기준 ClinicalTrials.gov는 미국과 221개국에서 2022년 39만 9,499건에서 43만 7,533건으로 눈에 띄게 증가했다고 보고했습니다. 이러한 임상시험 등록 건수의 급증은 임상시험의 성공, 정확한 데이터 수집, 환자 안전을 보장하는 데 중요한 임상시험 용품 시장의 확대를 촉진하는 주요 요인으로 작용하고 있습니다.

이 시장의 주요 기업은 헬스케어 의사결정, 의약품 개발, 환자 치료에 혁신을 가져오기 위해 혁신적인 기술을 도입하고 있습니다. 이러한 전략적 노력에는 실제 데이터를 활용하여 증거에 기반한 인사이트을 창출하는 것이 포함됩니다. 구체적인 예로, 2023년 4월 미국 헬스케어 기술 기업 코모도 헬스(Komodo Health)는 통합형 RWE(Real World Evidence) 기술 플랫폼인 'MapEnhance'를 발표했습니다. 전문 데이터 파트너 네트워크를 통합한 이 플랫폼은 임상 사건과 환자 집단에 대한 종합적인 관점을 제공합니다. MapEnhance는 정밀 분자진단, 표준 검사 진단, 전자의무기록을 아우르며 다양한 치료 영역과 병원 환경에서 타의 추종을 불허하는 인사이트을 제공합니다.

목차

제1장 개요

제2장 시장의 특징

제3장 시장 공급망 분석

제4장 세계 시장 동향과 전략

제5장 최종 용도 산업의 시장 분석

제6장 시장 : 금리, 인플레이션, 지정학, 무역 전쟁과 관세의 영향, 관세 전쟁과 무역 보호주의에 의한 공급망에 대한 영향, Covid가 시장에 미치는 영향을 포함한 거시경제 시나리오

제7장 세계의 전략 분석 프레임워크, 현재 시장 규모, 시장 비교 및 성장률 분석

제8장 시장의 세계 TAM(Total Addressable Market)

제9장 시장 세분화

제10장 지역별·국가별 분석

제11장 아시아태평양 시장

제12장 중국 시장

제13장 인도 시장

제14장 일본 시장

제15장 호주 시장

제16장 인도네시아 시장

제17장 한국 시장

제18장 대만 시장

제19장 동남아시아 시장

제20장 서유럽 시장

제21장 영국 시장

제22장 독일 시장

제23장 프랑스 시장

제24장 이탈리아 시장

제25장 스페인 시장

제26장 동유럽 시장

제27장 러시아 시장

제28장 북미 시장

제29장 미국 시장

제30장 캐나다 시장

제31장 남미 시장

제32장 브라질 시장

제33장 중동 시장

제34장 아프리카 시장

제35장 시장 규제 상황과 투자환경

제36장 경쟁 구도와 기업 개요

제37장 기타 대기업과 혁신적 기업

제38장 세계의 시장 경쟁 벤치마킹과 대시보드

제39장 주요 합병과 인수

제40장 시장의 잠재력이 높은 국가, 부문, 전략

제41장 부록

영문목차

Clinical trial supplies encompass materials, products, and equipment pivotal for the smooth conduct of clinical trials. They are instrumental in facilitating testing and evaluation processes.

Essential services related to clinical trial supplies involve logistics and distribution, storage and retention, supply chain management, packaging, labeling, blinding manufacturing, and comparator sourcing. Logistics and distribution manage the movement of trial supplies from manufacturing facilities to trial sites, ensuring prompt availability and efficient delivery. These supplies are crucial across various clinical phases (Phase I to Phase IV) for treating conditions such as oncology, CNS disorders, cardiovascular ailments, infectious diseases, metabolic disorders, among others. End users include pharmaceutical and biotech companies, contract research organizations (CROs), and medical device firms.

Tariffs are influencing the clinical trial supplies market by increasing costs of imported packaging materials, temperature-controlled containers, labeling components, and logistics equipment used across global trial supply chains. Pharmaceutical sponsors and CROs in North America and Europe are most affected due to reliance on cross-border sourcing, while Asia-Pacific faces cost pressure on export-oriented supply services. These tariffs are extending trial timelines and increasing operational budgets. However, they are also accelerating regional supply hub development, local packaging capabilities, and resilient sourcing strategies.

The clinical trial supplies market research report is one of a series of new reports from The Business Research Company that provides clinical trial supplies market statistics, including clinical trial supplies industry global market size, regional shares, competitors with a clinical trial supplies market share, detailed clinical trial supplies market segments, market trends and opportunities, and any further data you may need to thrive in the clinical trial supplies industry. This clinical trial supplies market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The clinical trial supplies market size has grown strongly in recent years. It will grow from $2.86 billion in 2025 to $3.1 billion in 2026 at a compound annual growth rate (CAGR) of 8.3%. The growth in the historic period can be attributed to increase in global clinical trial activity, expansion of multicenter trial designs, growth of biologics and specialty drugs, rising outsourcing to CROs, development of cold-chain logistics infrastructure.

The clinical trial supplies market size is expected to see strong growth in the next few years. It will grow to $4.33 billion in 2030 at a compound annual growth rate (CAGR) of 8.7%. The growth in the forecast period can be attributed to increasing complexity of clinical trial protocols, expansion of decentralized and virtual trials, rising focus on patient-centric trial models, growing investments in digital trial management tools, increasing regulatory scrutiny across regions. Major trends in the forecast period include increasing adoption of integrated supply chain platforms, rising use of temperature-controlled logistics solutions, growing demand for end-to-end trial visibility, expansion of adaptive packaging and labeling services, enhanced focus on compliance and traceability.

The clinical trial supplies market is poised for substantial growth, driven by the escalating number of registered clinical trials. These trials, essential for assessing the safety and efficacy of new medical treatments, interventions, and diagnostic procedures, rely on a range of supplies, including pharmaceuticals and medical devices. To illustrate, in May 2023, ClinicalTrials.gov reported a notable increase, with 437,533 registered clinical trials compared to 399,499 in 2022 across the United States and 221 countries. This surge in clinical trial registrations is a key factor fueling the expansion of the clinical trial supplies market, crucial for ensuring successful trials, accurate data collection, and patient safety.

Leading companies in this market are embracing innovative technologies to revolutionize healthcare decision-making, drug development, and patient care. This strategic move involves harnessing real-world data to generate evidence-based insights. As an illustration, in April 2023, Komodo Health, a US-based healthcare technology company, introduced MapEnhance-an integrated real-world evidence technology platform. This platform, incorporating a network of specialty data partners, provides customers with a comprehensive perspective on clinical events and patient populations. MapEnhance includes precision molecular diagnostics, standard laboratory diagnostics, and electronic medical records, offering unparalleled insights for various therapeutic areas and hospital settings.

In May 2024, Myonex, a pharmaceutical company based in the US, acquired Creapharm's pharmaceutical services for an undisclosed amount. Following this acquisition, Creapharm's capabilities in clinical packaging, distribution, commercial packaging, and bioservices will operate under the name Creapharm, a Myonex company. This merger enhances flexibility and strengthens service offerings for pharmaceutical and biotech companies at both clinical and commercial stages, including those involved with Advanced Therapies. Creapharm is a manufacturer of clinical trial supplies based in France.

Major companies operating in the clinical trial supplies market are Thermo Fisher Scientific Inc., IQVIA, Eurofins Scientific SE, Parexel International Corporation, ICON PLC, Catalent Inc., Intertek Group PLC, Recipharm AB, World Courier, Almac Group Ltd., Piramal Pharma Solutions, Clinigen Group PLC, Movianto GmbH, Marken Limited, PCI Pharma Services, Rubicon Research Private Limited, Bionical Ltd., Durbin PLC, SIRO Clinpharm Pvt. Ltd., Biocair International Ltd., Ancillare LP., Myonex, Klifo A/S, Alium Medical Limited, ADAllen Pharma, Sharp Services LLC

North America was the largest region in the clinical trial supplies market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the clinical trial supplies market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the clinical trial supplies market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The clinical trial supplies market consists of revenues earned by entities by providing quality control, regulatory compliance, and return and destruction management services. The market value includes the value of related goods sold by the service provider or included within the service offering. The clinical trial supplies market also includes sales of investigational products, comparator products, and clinical trial kits. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Clinical Trial Supplies Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses clinical trial supplies market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on end user analysis.
• Benchmark performance against key competitors based on market share, innovation, and brand strength.
• Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
• Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for clinical trial supplies ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The clinical trial supplies market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
• The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
• The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
• The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
• The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
• The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

• Markets Covered:1) By Services: Logistics And Distribution; Storage And Retention; Supply Chain Management; Packaging, Labeling, And Blinding; Comparator Sourcing
• 2) By Clinical Phases: Phase I; Phase II; Phase III; Phase IV
• 3) By Therapeutic Use: Oncology; Central Nervous System (CNS); Cardiovascular; Infectious Disease; Metabolic Disorders; Other Therapeutic Uses
• 4) By End User: Pharmaceutical And Biotech companies; Contract Research Organization (CRO)
• Subsegments:
• 1) By Logistics And Distribution: Transportation; Inventory Management; Temperature-Controlled Shipping; Customs Clearance
• 2) By Storage And Retention: Short-term Storage; Long-term Storage; Controlled Environment Storage
• 3) By Supply Chain Management: Planning And Forecasting; Supplier Management; Risk Management; Compliance Management
• 4) By Packaging, Labeling, And Blinding: Primary Packaging; Secondary Packaging; Label Design And Printing; Blinding Techniques
• 5) By Comparator Sourcing: Sourcing Of Reference Products; Quality Control And Assurance; Regulatory Compliance For Comparators
• Companies Mentioned: Thermo Fisher Scientific Inc.; IQVIA; Eurofins Scientific SE; Parexel International Corporation; ICON PLC; Catalent Inc.; Intertek Group PLC; Recipharm AB; World Courier; Almac Group Ltd.; Piramal Pharma Solutions; Clinigen Group PLC; Movianto GmbH; Marken Limited; PCI Pharma Services; Rubicon Research Private Limited; Bionical Ltd.; Durbin PLC; SIRO Clinpharm Pvt. Ltd.; Biocair International Ltd.; Ancillare LP.; Myonex; Klifo A/S; Alium Medical Limited; ADAllen Pharma; Sharp Services LLC
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: Word, PDF or Interactive Report
• + Excel Dashboard
• Added Benefits
• Bi-Annual Data Update
• Customisation
• Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

• 1.1. Key Market Insights (2020-2035)
• 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
• 1.3. Major Factors Driving the Market
• 1.4. Top Three Trends Shaping the Market

2. Clinical Trial Supplies Market Characteristics

• 2.1. Market Definition & Scope
• 2.2. Market Segmentations
• 2.3. Overview of Key Products and Services
• 2.4. Global Clinical Trial Supplies Market Attractiveness Scoring And Analysis
  • 2.4.1. Overview of Market Attractiveness Framework
  • 2.4.2. Quantitative Scoring Methodology
  • 2.4.3. Factor-Wise Evaluation
• Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
• 2.4.4. Market Attractiveness Scoring and Interpretation
• 2.4.5. Strategic Implications and Recommendations

3. Clinical Trial Supplies Market Supply Chain Analysis

• 3.1. Overview of the Supply Chain and Ecosystem
• 3.2. List Of Key Raw Materials, Resources & Suppliers
• 3.3. List Of Major Distributors and Channel Partners
• 3.4. List Of Major End Users

4. Global Clinical Trial Supplies Market Trends And Strategies

• 4.1. Key Technologies & Future Trends
  • 4.1.1 Biotechnology, Genomics And Precision Medicine
  • 4.1.2 Digitalization, Cloud, Big Data And Cybersecurity
  • 4.1.3 Industry 4.0 And Intelligent Manufacturing
  • 4.1.4 Internet Of Things (Iot), Smart Infrastructure And Connected Ecosystems
  • 4.1.5 Sustainability, Climate Tech And Circular Economy
• 4.2. Major Trends
  • 4.2.1 Increasing Adoption Of Integrated Supply Chain Platforms
  • 4.2.2 Rising Use Of Temperature-Controlled Logistics Solutions
  • 4.2.3 Growing Demand For End-To-End Trial Visibility
  • 4.2.4 Expansion Of Adaptive Packaging And Labeling Services
  • 4.2.5 Enhanced Focus On Compliance And Traceability

5. Clinical Trial Supplies Market Analysis Of End Use Industries

• 5.1 Pharmaceutical Companies
• 5.2 Biotechnology Companies
• 5.3 Contract Research Organizations
• 5.4 Medical Device Companies
• 5.5 Clinical Research Institutes

6. Clinical Trial Supplies Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Clinical Trial Supplies Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

• 7.1. Global Clinical Trial Supplies PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 7.2. Global Clinical Trial Supplies Market Size, Comparisons And Growth Rate Analysis
• 7.3. Global Clinical Trial Supplies Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
• 7.4. Global Clinical Trial Supplies Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Clinical Trial Supplies Total Addressable Market (TAM) Analysis for the Market

• 8.1. Definition and Scope of Total Addressable Market (TAM)
• 8.2. Methodology and Assumptions
• 8.3. Global Total Addressable Market (TAM) Estimation
• 8.4. TAM vs. Current Market Size Analysis
• 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Clinical Trial Supplies Market Segmentation

• 9.1. Global Clinical Trial Supplies Market, Segmentation By Services, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Logistics And Distribution, Storage And Retention, Supply Chain Management, Packaging, Labeling, And Blinding, Comparator Sourcing
• 9.2. Global Clinical Trial Supplies Market, Segmentation By Clinical Phases, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Phase I, Phase II, Phase III, Phase IV
• 9.3. Global Clinical Trial Supplies Market, Segmentation By Therapeutic Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Oncology, Central Nervous System (CNS), Cardiovascular, Infectious Disease, Metabolic Disorders, Other Therapeutic Uses
• 9.4. Global Clinical Trial Supplies Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Pharmaceutical And Biotech Companies, Contract Research Organization (CRO)
• 9.5. Global Clinical Trial Supplies Market, Sub-Segmentation Of Logistics And Distribution, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Transportation, Inventory Management, Temperature-Controlled Shipping, Customs Clearance
• 9.6. Global Clinical Trial Supplies Market, Sub-Segmentation Of Storage And Retention, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Short-term Storage, Long-term Storage, Controlled Environment Storage
• 9.7. Global Clinical Trial Supplies Market, Sub-Segmentation Of Supply Chain Management, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Planning And Forecasting, Supplier Management, Risk Management, Compliance Management
• 9.8. Global Clinical Trial Supplies Market, Sub-Segmentation Of Packaging, Labeling, And Blinding, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Primary Packaging, Secondary Packaging, Label Design And Printing, Blinding Techniques
• 9.9. Global Clinical Trial Supplies Market, Sub-Segmentation Of Comparator Sourcing, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Sourcing Of Reference Products, Quality Control And Assurance, Regulatory Compliance For Comparators

10. Clinical Trial Supplies Market Regional And Country Analysis

• 10.1. Global Clinical Trial Supplies Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• 10.2. Global Clinical Trial Supplies Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Clinical Trial Supplies Market

• 11.1. Asia-Pacific Clinical Trial Supplies Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 11.2. Asia-Pacific Clinical Trial Supplies Market, Segmentation By Services, Segmentation By Clinical Phases, Segmentation By Therapeutic Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Clinical Trial Supplies Market

• 12.1. China Clinical Trial Supplies Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 12.2. China Clinical Trial Supplies Market, Segmentation By Services, Segmentation By Clinical Phases, Segmentation By Therapeutic Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Clinical Trial Supplies Market

• 13.1. India Clinical Trial Supplies Market, Segmentation By Services, Segmentation By Clinical Phases, Segmentation By Therapeutic Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Clinical Trial Supplies Market

• 14.1. Japan Clinical Trial Supplies Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 14.2. Japan Clinical Trial Supplies Market, Segmentation By Services, Segmentation By Clinical Phases, Segmentation By Therapeutic Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Clinical Trial Supplies Market

• 15.1. Australia Clinical Trial Supplies Market, Segmentation By Services, Segmentation By Clinical Phases, Segmentation By Therapeutic Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Clinical Trial Supplies Market

• 16.1. Indonesia Clinical Trial Supplies Market, Segmentation By Services, Segmentation By Clinical Phases, Segmentation By Therapeutic Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Clinical Trial Supplies Market

• 17.1. South Korea Clinical Trial Supplies Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 17.2. South Korea Clinical Trial Supplies Market, Segmentation By Services, Segmentation By Clinical Phases, Segmentation By Therapeutic Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Clinical Trial Supplies Market

• 18.1. Taiwan Clinical Trial Supplies Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 18.2. Taiwan Clinical Trial Supplies Market, Segmentation By Services, Segmentation By Clinical Phases, Segmentation By Therapeutic Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Clinical Trial Supplies Market

• 19.1. South East Asia Clinical Trial Supplies Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 19.2. South East Asia Clinical Trial Supplies Market, Segmentation By Services, Segmentation By Clinical Phases, Segmentation By Therapeutic Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Clinical Trial Supplies Market

• 20.1. Western Europe Clinical Trial Supplies Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 20.2. Western Europe Clinical Trial Supplies Market, Segmentation By Services, Segmentation By Clinical Phases, Segmentation By Therapeutic Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Clinical Trial Supplies Market

• 21.1. UK Clinical Trial Supplies Market, Segmentation By Services, Segmentation By Clinical Phases, Segmentation By Therapeutic Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Clinical Trial Supplies Market

• 22.1. Germany Clinical Trial Supplies Market, Segmentation By Services, Segmentation By Clinical Phases, Segmentation By Therapeutic Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Clinical Trial Supplies Market

• 23.1. France Clinical Trial Supplies Market, Segmentation By Services, Segmentation By Clinical Phases, Segmentation By Therapeutic Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Clinical Trial Supplies Market

• 24.1. Italy Clinical Trial Supplies Market, Segmentation By Services, Segmentation By Clinical Phases, Segmentation By Therapeutic Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Clinical Trial Supplies Market

• 25.1. Spain Clinical Trial Supplies Market, Segmentation By Services, Segmentation By Clinical Phases, Segmentation By Therapeutic Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Clinical Trial Supplies Market

• 26.1. Eastern Europe Clinical Trial Supplies Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 26.2. Eastern Europe Clinical Trial Supplies Market, Segmentation By Services, Segmentation By Clinical Phases, Segmentation By Therapeutic Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Clinical Trial Supplies Market

• 27.1. Russia Clinical Trial Supplies Market, Segmentation By Services, Segmentation By Clinical Phases, Segmentation By Therapeutic Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Clinical Trial Supplies Market

• 28.1. North America Clinical Trial Supplies Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 28.2. North America Clinical Trial Supplies Market, Segmentation By Services, Segmentation By Clinical Phases, Segmentation By Therapeutic Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Clinical Trial Supplies Market

• 29.1. USA Clinical Trial Supplies Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 29.2. USA Clinical Trial Supplies Market, Segmentation By Services, Segmentation By Clinical Phases, Segmentation By Therapeutic Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Clinical Trial Supplies Market

• 30.1. Canada Clinical Trial Supplies Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 30.2. Canada Clinical Trial Supplies Market, Segmentation By Services, Segmentation By Clinical Phases, Segmentation By Therapeutic Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Clinical Trial Supplies Market

• 31.1. South America Clinical Trial Supplies Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 31.2. South America Clinical Trial Supplies Market, Segmentation By Services, Segmentation By Clinical Phases, Segmentation By Therapeutic Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Clinical Trial Supplies Market

• 32.1. Brazil Clinical Trial Supplies Market, Segmentation By Services, Segmentation By Clinical Phases, Segmentation By Therapeutic Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Clinical Trial Supplies Market

• 33.1. Middle East Clinical Trial Supplies Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 33.2. Middle East Clinical Trial Supplies Market, Segmentation By Services, Segmentation By Clinical Phases, Segmentation By Therapeutic Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Clinical Trial Supplies Market

• 34.1. Africa Clinical Trial Supplies Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 34.2. Africa Clinical Trial Supplies Market, Segmentation By Services, Segmentation By Clinical Phases, Segmentation By Therapeutic Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Clinical Trial Supplies Market Regulatory and Investment Landscape

36. Clinical Trial Supplies Market Competitive Landscape And Company Profiles

• 36.1. Clinical Trial Supplies Market Competitive Landscape And Market Share 2024
  • 36.1.1. Top 10 Companies (Ranked by revenue/share)
• 36.2. Clinical Trial Supplies Market - Company Scoring Matrix
  • 36.2.1. Market Revenues
  • 36.2.2. Product Innovation Score
  • 36.2.3. Brand Recognition
• 36.3. Clinical Trial Supplies Market Company Profiles
  • 36.3.1. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.2. IQVIA Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.3. Eurofins Scientific SE Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.4. Parexel International Corporation Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.5. ICON PLC Overview, Products and Services, Strategy and Financial Analysis

37. Clinical Trial Supplies Market Other Major And Innovative Companies

• Catalent Inc., Intertek Group PLC, Recipharm AB, World Courier, Almac Group Ltd., Piramal Pharma Solutions, Clinigen Group PLC, Movianto GmbH, Marken Limited, PCI Pharma Services, Rubicon Research Private Limited, Bionical Ltd., Durbin PLC, SIRO Clinpharm Pvt. Ltd., Biocair International Ltd.

38. Global Clinical Trial Supplies Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Clinical Trial Supplies Market

40. Clinical Trial Supplies Market High Potential Countries, Segments and Strategies

• 40.1 Clinical Trial Supplies Market In 2030 - Countries Offering Most New Opportunities
• 40.2 Clinical Trial Supplies Market In 2030 - Segments Offering Most New Opportunities
• 40.3 Clinical Trial Supplies Market In 2030 - Growth Strategies
  • 40.3.1 Market Trend Based Strategies
  • 40.3.2 Competitor Strategies

41. Appendix

• 41.1. Abbreviations
• 41.2. Currencies
• 41.3. Historic And Forecast Inflation Rates
• 41.4. Research Inquiries
• 41.5. The Business Research Company
• 41.6. Copyright And Disclaimer